Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals has achieved a 52-week high, demonstrating strong performance by outperforming its sector and recording significant gains over the past few days. The stock is trading above multiple moving averages and has delivered impressive annual returns, highlighting its favorable market position and resilience.

Kwality Pharmaceuticals has achieved a new 52-week high, reaching Rs. 1039 on January 14, 2025. The small-cap company has shown strong performance, with consecutive gains over three days and a notable annual increase of 116.87%, significantly surpassing the Sensex's growth during the same timeframe.

Kwality Pharmaceuticals has achieved a 52-week high, reflecting strong investor confidence and a notable performance in the market. The stock has outperformed its sector and delivered impressive annual returns, significantly exceeding broader market indices. Its consistent trading above key moving averages indicates robust short- and medium-term performance.

Kwality Pharmaceuticals has reached a new 52-week high, reflecting strong market momentum. The stock has seen a revision in its score, indicating a positive adjustment in evaluation. Additionally, it has been added to MarketsMOJO's list, underscoring its impressive growth and performance relative to the broader market.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has reported positive financial results for the quarter ending September 2024. The company's operating profit to interest ratio has improved, while its PBT, net sales, and PAT have shown significant growth. MarketsMOJO has given a 'Hold' call for the company's stock.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has reached a 52-week high with its stock price at Rs.961.15 on November 4th, 2024. The stock has outperformed the sector by 1.77% and gained 28.06% in the last 6 days. With a strong performance and positive market sentiment, the stock is currently trading above its moving averages and has shown a remarkable 1-year performance of 180.03% compared to the Sensex's 21.91%. MarketsMOJO has given a 'Hold' call for the stock, indicating its potential in the industry.

Kwality Pharmaceuticals, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 885 on October 31, 2024. The company's stock has been on an upward trend for the past four days, outperforming the sector by 1.14%. With a strong track record and a 'Hold' rating from MarketsMOJO, Kwality Pharma is poised for continued success in the pharmaceutical industry.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has been downgraded to a 'Hold' by MarketsMOJO due to its high debt servicing ability and positive financial results in the first half of 2024. However, the stock is currently trading at a premium and lacks interest from domestic mutual funds.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, received a 'Buy' rating from MarketsMOJO on October 25, 2024. The company's low Debt to EBITDA ratio and positive financial results in the first half of 2024 have contributed to this upgrade. Technical indicators also show a bullish trend, making it an attractive option for investors. However, the lack of confidence from domestic mutual funds should be considered before investing.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has been downgraded to a 'Hold' by MarketsMOJO due to its strong ability to service debt, positive financial results, and bullish technical trends. However, the stock is currently trading at a premium and has low interest from domestic mutual funds, indicating potential caution for investors.

Kwality Pharmaceuticals, a microcap pharmaceutical company, has received a 'Buy' rating from MarketsMOJO due to its strong ability to manage debt, positive financial results, and bullish technical trend. However, investors should be aware of potential risks, such as the low stake held by domestic mutual funds.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has recently seen a surge in its stock price, reaching a 52-week high of Rs. 864.9 on September 13, 2024. With a 'Hold' recommendation from MarketsMOJO, the company's performance is in line with the sector and has outperformed the Sensex in the past year.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has seen a surge in its stock price, reaching a 52-week high of Rs. 859.45 on September 12, 2024. The stock has outperformed the sector and is currently trading higher than its moving averages, showcasing its strong growth potential and positive performance.

Kwality Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has seen a surge in its stock price, reaching a 52-week high of Rs. 847 on September 11, 2024. The stock has outperformed the sector by 3.43% and is trading higher than its moving averages, indicating a positive trend. With a remarkable growth of 111.61% in the past year, Kwality Pharmaceuticals is poised for further success in the highly competitive pharmaceutical market.

Kwality Pharmaceuticals, a microcap company in the pharmaceutical industry, has recently seen a surge in its stock price, reaching a 52-week high of Rs. 796.4 on September 3rd, 2024. The stock has outperformed the sector by 1.88% and is currently trading above its moving averages, with a remarkable growth of 107.42% in the past year.

Kwality Pharmaceuticals, a microcap company in the pharma industry, has been downgraded to a 'Hold' by MarketsMOJO on September 2, 2024. This is due to factors such as the company's strong ability to service its debt, positive financial results, and technical trends. However, the company's profits have only risen by 1.9%, resulting in a PEG ratio of 13.7. Investors should carefully consider their options before making any decisions regarding this company.

Kwality Pharmaceuticals, a microcap company in the pharma industry, has reached a 52-week high of Rs. 794 on September 2nd, 2024. With a 'Buy' call from MarketsMOJO and outperforming its sector by 4.11%, the company has shown strong performance and potential for growth. It has also outperformed the Sensex by 105.01% in the past year.

Kwality Pharmaceuticals, a microcap company in the pharma industry, has been gaining attention in the stock market with its recent performance. Its stock price reached a 52-week high of Rs. 790 on August 26th, outperforming the sector by 4.13% and showing a consecutive gain for the last 2 days. With a 'Buy' call from MarketsMOJO and trading above its moving averages, the company has shown strong potential for growth.

Kwality Pharmaceuticals, a microcap company in the pharma industry, has been making waves in the stock market with its recent performance. On August 23, 2024, the company's stock price reached a 52-week high of Rs.730.05, outperforming the sector by 4.7%. With a remarkable growth of 91.70% in the past year, Kwality Pharma is a promising player in the market.